Alpha-herpesvirus insensitive monoclonal cell strain, and preparation method therefor and use thereof
US12331321B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2024 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Nov 29, 2044 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure discloses an α-herpesvirus insensitive monoclonal cell strain, and a preparation method therefor and use thereof, belonging to the technical field of biomedicine. In order to perform targeted research of intercellular transmission of an α-herpesvirus and an action mechanism thereof, the present disclosure discloses the α-herpesvirus insensitive monoclonal cell strain. The cell strain is named as a human liver cancer continuous cell line Huh7-C10 and has a potential of being applied to developing a new generation of enhanced oncolytic herpesvirus and single-round infection attenuated live vaccine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.